The American Society of Clinical Oncology and Society of Surgical Oncology (ASCO) recently published guidelines for germline testing in patients with breast cancer.4BRCA1 and BRCA2 testing should be offered to all patients with stage I to III or de novo stage IV or metastatic breast cancer who are aged 65 years or younger at diagnosis. Here, BRCA2 is linked to breast cancer.